Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cytotoxicity
100%
Acute Lymphoblastic Leukemia
100%
Immunotoxin
100%
CD22
100%
Pediatric Acute Lymphoblastic Leukemia
100%
CAT-8015
100%
Lethal Concentration
50%
Acute Lymphoblastic Leukemia Cells
50%
No Significant Difference
25%
Cancer Causes
25%
Cancer Mortality
25%
Pediatric
25%
Bone Marrow
25%
Improved Outcomes
25%
Peripheral Blood
25%
Cell Viability
25%
Multidrug-resistant
25%
Newly Diagnosed
25%
Truncated Protein
25%
Patient Samples
25%
In Vitro Cytotoxicity
25%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
25%
Inter-patient Variability
25%
Relapsed Patients
25%
Cell Culture Assay
25%
Clinical Testing
25%
Bone Marrow Mesenchymal Cells
25%
Pseudomonas Exotoxin A
25%
High-risk Acute Leukemia
25%
Mesenchymal Cell Culture
25%
Medicine and Dentistry
Pediatrics
100%
Acute Lymphoblastic Leukemia
100%
Cytotoxicity
100%
Moxetumomab Pasudotox
100%
Anti-CD22 Immunotoxin
100%
Leukemia Cell
25%
In Vitro
12%
Malignant Neoplasm
12%
Cell Viability
12%
Immunotoxin
12%
Cell Culture Assays
12%
Pseudomonas Exotoxin
12%
Derived Protein
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cytotoxicity
100%
Acute Lymphoblastic Leukemia
100%
Anti-CD22 Immunotoxin
100%
Moxetumomab Pasudotox
100%
Malignant Neoplasm
12%
Cell Culture
12%
Cell Viability
12%
Immunotoxin
12%
Pseudomonas Exotoxin
12%
Immunology and Microbiology
Cytotoxicity
100%
CD22
100%
Moxetumomab Pasudotox
100%
Leukemia Cell
25%
LC50
25%
Lineages
12%
Exotoxin
12%
Cell Culture
12%
Cell Viability
12%
Pseudomonas
12%
Immunotoxin
12%
Derived Protein
12%